Biosimilars: innovation for life
Biologics is Kern Pharma's division focused on biosimilar medicines.
Kern Pharma makes available to patients in Spain and Portugal monoclonal antibodies approved by the EMA (European Medicines Agency): Infliximab, Adalimumab and Ustekinumab.